ATE191846T1 - Tabletten mit verbesserter verschleissfestigkeit und verfahren zu ihrer herstellung - Google Patents

Tabletten mit verbesserter verschleissfestigkeit und verfahren zu ihrer herstellung

Info

Publication number
ATE191846T1
ATE191846T1 AT94101809T AT94101809T ATE191846T1 AT E191846 T1 ATE191846 T1 AT E191846T1 AT 94101809 T AT94101809 T AT 94101809T AT 94101809 T AT94101809 T AT 94101809T AT E191846 T1 ATE191846 T1 AT E191846T1
Authority
AT
Austria
Prior art keywords
oily
fatty substance
excipient
compression
active ingredient
Prior art date
Application number
AT94101809T
Other languages
German (de)
English (en)
Inventor
Hiroshi Matoba
Hiroyoshi Koyama
Junichi Kikuta
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE191846T1 publication Critical patent/ATE191846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2210/00—Fluid
    • F04C2210/26—Refrigerants with particular properties, e.g. HFC-134a

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94101809T 1993-02-10 1994-02-07 Tabletten mit verbesserter verschleissfestigkeit und verfahren zu ihrer herstellung ATE191846T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4595893 1993-02-10

Publications (1)

Publication Number Publication Date
ATE191846T1 true ATE191846T1 (de) 2000-05-15

Family

ID=12733779

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94101809T ATE191846T1 (de) 1993-02-10 1994-02-07 Tabletten mit verbesserter verschleissfestigkeit und verfahren zu ihrer herstellung

Country Status (10)

Country Link
US (1) US5456920A (cg-RX-API-DMAC10.html)
EP (1) EP0610854B1 (cg-RX-API-DMAC10.html)
KR (1) KR940019294A (cg-RX-API-DMAC10.html)
CN (1) CN1106652A (cg-RX-API-DMAC10.html)
AT (1) ATE191846T1 (cg-RX-API-DMAC10.html)
CA (1) CA2115308C (cg-RX-API-DMAC10.html)
DE (1) DE69423990T2 (cg-RX-API-DMAC10.html)
FI (1) FI940585L (cg-RX-API-DMAC10.html)
NO (1) NO940373L (cg-RX-API-DMAC10.html)
TW (1) TW272942B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331839T2 (de) * 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
TW466119B (en) * 1994-02-28 2001-12-01 Janssen Pharmaceutica Nv Film coated tablet of paracetamol and domperidone
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
CN1220598A (zh) * 1996-05-02 1999-06-23 大正制药株式会社 水难溶性酸性药物的悬浮液
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
AU1234399A (en) * 1997-11-25 1999-06-15 Bayer Aktiengesellschaft Sustained release formulations comprising alpha-glucosidase-i nhibitors
WO1999050217A1 (en) * 1998-03-31 1999-10-07 Bayer Aktiengesellschaft Valiolone, a method of preparing it, and its use to prepare acarbose and voglibose
CH689452C1 (de) * 1998-04-15 2004-11-30 Marcel Christian Wegmueller Verfahren zur Verhinderung von zementbedingten ablagerungen in einem Bauwerksentwaesserungssystem.
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2377847T3 (es) 1999-01-13 2012-04-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
DE60039379D1 (de) * 1999-02-10 2008-08-21 Pfizer Prod Inc Pharmazeutische feste Dispersionen
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
CA2376202C (en) * 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel preparation and administration form comprising an acid-labile active compound
WO2001015665A1 (en) 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
US20070059367A1 (en) * 2000-06-06 2007-03-15 Cherukuri S R Drug Delivery System and Associated Methods
US20100196466A1 (en) * 2000-06-06 2010-08-05 Capricorn Pharma Inc. Drug delivery system
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
CN1596104A (zh) 2001-09-28 2005-03-16 麦克内尔-Ppc股份有限公司 改进的释放剂型
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
US7011688B2 (en) * 2002-05-10 2006-03-14 C.R. Bard, Inc. Prosthetic repair fabric
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
WO2004093850A1 (en) * 2003-04-24 2004-11-04 Jagotec Ag Tablet with coloured core
ES2288694T3 (es) 2003-05-20 2008-01-16 Bayer Pharmaceuticals Corporation Diaril ureas para enfermedades mediadas por el receptor del factor de crecimiento derivado de plaquetas.
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
FR2862187B1 (fr) * 2003-11-19 2006-02-24 Sbm Dev Nouvelles compositions agrochimiques et leur procede de fabrication
FR2867025B1 (fr) * 2004-03-05 2006-06-02 Sbm Dev Compositions agrochimiques solides a desagregation rapide
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
DE102005028696A1 (de) * 2005-06-21 2006-12-28 Pulmotec Gmbh Verwendung eines Hilfsstoffs zur Einstellung der Abrasionsfestigkeit eines verfestigten Wirkstoffpräparats
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
TW200829286A (en) * 2006-09-06 2008-07-16 Genzyme Corp Polystyrene sulfonate polymer tablets, their preparation and use
DE602007011792D1 (de) * 2006-10-27 2011-02-17 Fmc Corp Gemeinsam aufbereitete mikrokristalline cellulose und zuckeralkohol als hilfsstoff für tablettenformulierungen
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
EP3811371A1 (en) 2018-06-21 2021-04-28 Aquestive Therapeutics, Inc. System and method for making personalized individual unit doses containing pharmaceutical actives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070127A3 (en) * 1981-07-10 1983-08-17 Beecham Group Plc Tablets
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
JPH0425926A (ja) * 1990-05-22 1992-01-29 Toshiba Corp 情報処理装置
TW284688B (cg-RX-API-DMAC10.html) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
FI940585A7 (fi) 1994-08-11
FI940585A0 (fi) 1994-02-09
NO940373D0 (no) 1994-02-04
DE69423990D1 (de) 2000-05-25
EP0610854A1 (en) 1994-08-17
EP0610854B1 (en) 2000-04-19
TW272942B (cg-RX-API-DMAC10.html) 1996-03-21
DE69423990T2 (de) 2000-08-17
US5456920A (en) 1995-10-10
CA2115308C (en) 2004-05-11
NO940373L (no) 1994-08-11
CA2115308A1 (en) 1994-08-11
KR940019294A (ko) 1994-09-14
FI940585L (fi) 1994-08-11
CN1106652A (zh) 1995-08-16

Similar Documents

Publication Publication Date Title
ATE191846T1 (de) Tabletten mit verbesserter verschleissfestigkeit und verfahren zu ihrer herstellung
DE69000240D1 (de) Nifedipine enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
HU9300700D0 (en) Concentrated solid dosing forms with high active agent content such as pills, granular powders and pellets
CA2006028A1 (fr) Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
CA2027753A1 (en) Deodorizing and cleaning compositions and method
SE8505099D0 (sv) Pulver med reglerad frigoring samt sett for framstellning derav
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
ATE138049T1 (de) Oxidpulver, sinterkörper, verfahren zu dessen herstellung und daraus zusammengesetztes target
FI945452A0 (fi) Ibuprofeenia sisältävä poreileva lääkevalmiste sekä sen valmistusmenetelmä
YU13794A (sh) Nova jedinjenja polijodida, njihovo pripremanje i njihova primena kao kontrast za rendgenska snimanja
EP0068450A3 (en) Pharmaceutical forms for oral administration
BR9813149A (pt) Complexo de carragenano, processo para preparação do mesmo, composição farmacêutica de liberação controlada, e, processos pra preparar composições farmecêuticas de liberação controlada na forma de tabletes e na forma de glânulos ou na forma de pelotas
FR2656772B1 (fr) Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants.
JPS57134532A (en) Electrical contact material of silver-tin-bismuth alloy
BR0006230B1 (pt) Composição na forma de um pó ou grânulos compreendendo ácido ascórbico e pectina, e processo para sua preparação
IT1205784B (it) Composizione deodorante in polvere per scarpe,in particolare scarpe per attivita' sportive
DE3673937D1 (de) Pellets mit irregulaerer oberflaeche, verfahren zu deren herstellung und tabletten enthaltend diese pellets.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
TH15700A (th) เม็ดที่ไม่มีการเคลือบ และวิธีการผลิตเม็ดดังกล่าว
JPS5282715A (en) Long acting drug composition
JPS57156436A (en) Angelic ester derivative and perfume composition comprising it
JPS5695143A (en) 4-substituted nonanal and its preparation
EP0416722A3 (en) Pharmaceutical compositions having differential drug release rate
Nishikawa et al. Composition of Stabilized Synthetic Resin
GB2333452A (en) A bolus containing an oily substance such as Vitamin E for ruminant animals

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties